Cargando…
Role of molecular signature to differentiate second primary lung cancer from metastasis in a patient with squamous cell carcinoma of oral cavity
BACKGROUND: Lung is the most common site of distant metastasis for patients with head and neck squamous cell carcinoma (HNSCC). However, differentiating second primary lung cancers from metastasis may be difficult for p16 negative HNSCC. CASE: We describe a case of oral cavity squamous cell carcinom...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388157/ https://www.ncbi.nlm.nih.gov/pubmed/34161676 http://dx.doi.org/10.1002/cnr2.1363 |
_version_ | 1783742586975944704 |
---|---|
author | Yilmaz, Emrullah Gan, Gregory N. Schroeder, Thomas M. Cowan, Andrew Joste, Nancy |
author_facet | Yilmaz, Emrullah Gan, Gregory N. Schroeder, Thomas M. Cowan, Andrew Joste, Nancy |
author_sort | Yilmaz, Emrullah |
collection | PubMed |
description | BACKGROUND: Lung is the most common site of distant metastasis for patients with head and neck squamous cell carcinoma (HNSCC). However, differentiating second primary lung cancers from metastasis may be difficult for p16 negative HNSCC. CASE: We describe a case of oral cavity squamous cell carcinoma (SCC) who was found to have lung nodule and hilar lymphadenopathy (LAD) after surgery and radiation therapy. Hilar node was consistent with SCC however, it was difficult to differentiate second primary lung cancer and metastasis from oral cavity SCC. Next‐generation sequencing was done for the primary oral cavity and the hilar node. Both samples had the same type of TP53 mutation and variants of unknown significance suggesting metastatic HNSCC. He was treated with a chemotherapy regimen for metastatic HNSCC. CONCLUSION: Molecular studies can help to differentiate metastasis from second primary lung cancers for p16 negative HNSCC. |
format | Online Article Text |
id | pubmed-8388157 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-83881572021-08-31 Role of molecular signature to differentiate second primary lung cancer from metastasis in a patient with squamous cell carcinoma of oral cavity Yilmaz, Emrullah Gan, Gregory N. Schroeder, Thomas M. Cowan, Andrew Joste, Nancy Cancer Rep (Hoboken) Case Reports BACKGROUND: Lung is the most common site of distant metastasis for patients with head and neck squamous cell carcinoma (HNSCC). However, differentiating second primary lung cancers from metastasis may be difficult for p16 negative HNSCC. CASE: We describe a case of oral cavity squamous cell carcinoma (SCC) who was found to have lung nodule and hilar lymphadenopathy (LAD) after surgery and radiation therapy. Hilar node was consistent with SCC however, it was difficult to differentiate second primary lung cancer and metastasis from oral cavity SCC. Next‐generation sequencing was done for the primary oral cavity and the hilar node. Both samples had the same type of TP53 mutation and variants of unknown significance suggesting metastatic HNSCC. He was treated with a chemotherapy regimen for metastatic HNSCC. CONCLUSION: Molecular studies can help to differentiate metastasis from second primary lung cancers for p16 negative HNSCC. John Wiley and Sons Inc. 2021-06-23 /pmc/articles/PMC8388157/ /pubmed/34161676 http://dx.doi.org/10.1002/cnr2.1363 Text en © 2021 The Authors. Cancer Reports published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Reports Yilmaz, Emrullah Gan, Gregory N. Schroeder, Thomas M. Cowan, Andrew Joste, Nancy Role of molecular signature to differentiate second primary lung cancer from metastasis in a patient with squamous cell carcinoma of oral cavity |
title | Role of molecular signature to differentiate second primary lung cancer from metastasis in a patient with squamous cell carcinoma of oral cavity |
title_full | Role of molecular signature to differentiate second primary lung cancer from metastasis in a patient with squamous cell carcinoma of oral cavity |
title_fullStr | Role of molecular signature to differentiate second primary lung cancer from metastasis in a patient with squamous cell carcinoma of oral cavity |
title_full_unstemmed | Role of molecular signature to differentiate second primary lung cancer from metastasis in a patient with squamous cell carcinoma of oral cavity |
title_short | Role of molecular signature to differentiate second primary lung cancer from metastasis in a patient with squamous cell carcinoma of oral cavity |
title_sort | role of molecular signature to differentiate second primary lung cancer from metastasis in a patient with squamous cell carcinoma of oral cavity |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388157/ https://www.ncbi.nlm.nih.gov/pubmed/34161676 http://dx.doi.org/10.1002/cnr2.1363 |
work_keys_str_mv | AT yilmazemrullah roleofmolecularsignaturetodifferentiatesecondprimarylungcancerfrommetastasisinapatientwithsquamouscellcarcinomaoforalcavity AT gangregoryn roleofmolecularsignaturetodifferentiatesecondprimarylungcancerfrommetastasisinapatientwithsquamouscellcarcinomaoforalcavity AT schroederthomasm roleofmolecularsignaturetodifferentiatesecondprimarylungcancerfrommetastasisinapatientwithsquamouscellcarcinomaoforalcavity AT cowanandrew roleofmolecularsignaturetodifferentiatesecondprimarylungcancerfrommetastasisinapatientwithsquamouscellcarcinomaoforalcavity AT jostenancy roleofmolecularsignaturetodifferentiatesecondprimarylungcancerfrommetastasisinapatientwithsquamouscellcarcinomaoforalcavity |